Jiang-Dong Sui

601 total citations
27 papers, 405 citations indexed

About

Jiang-Dong Sui is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiang-Dong Sui has authored 27 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiang-Dong Sui's work include DNA Repair Mechanisms (4 papers), Immune cells in cancer (4 papers) and Head and Neck Cancer Studies (4 papers). Jiang-Dong Sui is often cited by papers focused on DNA Repair Mechanisms (4 papers), Immune cells in cancer (4 papers) and Head and Neck Cancer Studies (4 papers). Jiang-Dong Sui collaborates with scholars based in China, United States and Finland. Jiang-Dong Sui's co-authors include Benjamin P.C. Chen, Shichuan Zhang, Yu‐Fen Lin, Chengyuan Qian, Mengqi Yang, Dong Wang, Hua Li, Fei Yang, Bing Zhong and Kyung Jong Lee and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Jiang-Dong Sui

23 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiang-Dong Sui China 11 279 137 91 45 44 27 405
S.N. Kehlet Denmark 12 114 0.4× 122 0.9× 59 0.6× 100 2.2× 60 1.4× 17 386
Zuyu Liang China 7 121 0.4× 81 0.6× 119 1.3× 46 1.0× 75 1.7× 12 281
Michael Frost United States 8 215 0.8× 173 1.3× 78 0.9× 27 0.6× 32 0.7× 11 400
Hiromitsu Komiyama Japan 10 198 0.7× 142 1.0× 73 0.8× 90 2.0× 69 1.6× 38 431
Naoshi Kawamura Japan 10 156 0.6× 233 1.7× 204 2.2× 57 1.3× 46 1.0× 12 456
Benjamin Schoeps Germany 8 144 0.5× 123 0.9× 132 1.5× 128 2.8× 69 1.6× 11 406
Tingyue Zhou China 9 133 0.5× 118 0.9× 126 1.4× 37 0.8× 22 0.5× 9 306
Liting You China 9 182 0.7× 152 1.1× 73 0.8× 65 1.4× 63 1.4× 25 412
Thomas S. DeNapoli United States 6 116 0.4× 72 0.5× 123 1.4× 55 1.2× 35 0.8× 12 295

Countries citing papers authored by Jiang-Dong Sui

Since Specialization
Citations

This map shows the geographic impact of Jiang-Dong Sui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiang-Dong Sui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiang-Dong Sui more than expected).

Fields of papers citing papers by Jiang-Dong Sui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiang-Dong Sui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiang-Dong Sui. The network helps show where Jiang-Dong Sui may publish in the future.

Co-authorship network of co-authors of Jiang-Dong Sui

This figure shows the co-authorship network connecting the top 25 collaborators of Jiang-Dong Sui. A scholar is included among the top collaborators of Jiang-Dong Sui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiang-Dong Sui. Jiang-Dong Sui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Yipeng, Huan Zhang, Honglei Tu, et al.. (2025). Monocyte count combined with GTVnx is an independent prognostic factor in non-metastatic nasopharyngeal carcinoma receiving radiotherapy. Frontiers in Oncology. 15. 1541212–1541212.
2.
Zhang, Xintong, et al.. (2025). High-cis astaxanthin nano lipid carrier: Preparation and bioavailability analysis. Food Bioscience. 68. 106780–106780.
3.
Xia, F., et al.. (2025). Adverse event profile of crizotinib in real-world from the FAERS database: a 12-year pharmacovigilance study. BMC Pharmacology and Toxicology. 26(1). 61–61. 7 indexed citations
4.
Sui, Jiang-Dong, et al.. (2024). Long‐term survival after immunotherapy for uncontrolled locally advanced temporal bone squamous cell carcinoma followed by chemoradiotherapy: A case report. SHILAP Revista de lepidopterología. 8(2). 99–105. 1 indexed citations
5.
Yang, Haonan, Lei Zheng, Jiang He, et al.. (2024). Single-cell RNA sequencing reveals recruitment of the M2-like CCL8high macrophages in Lewis lung carcinoma-bearing mice following hypofractionated radiotherapy. Journal of Translational Medicine. 22(1). 306–306. 7 indexed citations
6.
Zheng, Lei, Haonan Yang, Lu Zhang, et al.. (2024). Global profiling of transcriptome, proteome and 2-hydroxyisobutyrylome in radioresistant lung adenocarcinoma cell. BMC Genomics. 25(1). 923–923. 1 indexed citations
7.
Zhang, Lu, Haonan Yang, Ying Wang, et al.. (2024). The effectiveness of targeted therapy for recurrence or metastasis adenoid cystic carcinoma: a systematic review and meta-analysis. Annals of Medicine. 56(1). 2399867–2399867. 3 indexed citations
8.
9.
Tang, Zheng, et al.. (2022). Radiation-induced PD-L1 expression in tumor and its microenvironment facilitates cancer-immune escape: a narrative review. Annals of Translational Medicine. 10(24). 1406–1406. 57 indexed citations
10.
Yang, Mengqi, et al.. (2022). Reduced-dose radiation in human papillomavirus-associated oropharyngeal carcinoma can improve outcome: a systematic review and meta-analysis. Annals of Translational Medicine. 10(24). 1391–1391. 5 indexed citations
11.
Sui, Jiang-Dong, Ying Wang, Yongzhong Wu, et al.. (2022). Radiation-induced eosinophil increase ratio predicts patient outcomes in non-small celllung cancer. Frontiers in Oncology. 12. 999555–999555. 1 indexed citations
12.
13.
14.
Sui, Jiang-Dong, et al.. (2018). Risk of hematologic toxicities with programmed cell death-1 inhibitors in cancer patients: a meta-analysis of current studies. Drug Design Development and Therapy. Volume 12. 1645–1657. 15 indexed citations
15.
Sui, Jiang-Dong, Yu‐Fen Lin, Kangling Xu, et al.. (2015). DNA-PKcs phosphorylates hnRNP-A1 to facilitate the RPA-to-POT1 switch and telomere capping after replication. Nucleic Acids Research. 43(12). 5971–5983. 48 indexed citations
16.
Zhang, Siyuan, Satoru Matsunaga, Yu‐Fen Lin, et al.. (2015). Spontaneous tumor development in bone marrow-rescued DNA-PKcs3A/3A mice due to dysfunction of telomere leading strand deprotection. Oncogene. 35(30). 3909–3918. 18 indexed citations
17.
Wang, Dong, Jiang-Dong Sui, Mengxia Li, et al.. (2014). Functional analysis of tanshinone IIA that blocks the redox function of human apurinic/apyrimidinic endonuclease 1/redox factor-1. Drug Design Development and Therapy. 8. 2147–2147. 7 indexed citations
18.
Wang, Dong, Mengxia Li, Jiang-Dong Sui, et al.. (2014). Identification of a novel potential antitumor activity of gossypol as an APE1/Ref-1 inhibitor. Drug Design Development and Therapy. 8. 485–485. 28 indexed citations
19.
Cun, Yanping, Nan Dai, Mengxia Li, et al.. (2013). APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner. Oncology Reports. 31(2). 901–909. 14 indexed citations
20.
Sui, Jiang-Dong, Hua Li, Yongfei Fang, et al.. (2011). NLRP1 gene polymorphism influences gene transcription and is a risk factor for rheumatoid arthritis in Han Chinese. Arthritis & Rheumatism. 64(3). 647–654. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S.N. Kehlet Breakdown of academic impact, for papers by Zuyu Liang Breakdown of academic impact, for papers by Michael Frost Breakdown of academic impact, for papers by Hiromitsu Komiyama Breakdown of academic impact, for papers by Naoshi Kawamura Breakdown of academic impact, for papers by Benjamin Schoeps Breakdown of academic impact, for papers by Tingyue Zhou Breakdown of academic impact, for papers by Liting You Breakdown of academic impact, for papers by Thomas S. DeNapoli
Rankless by CCL
2026